There was also a nonsignificant trend toward reduced risk for the primary end point (nonfatal and fatal MI) favoring amlodipine/perindopril treatment [ 24 ].
1
—
—
There was also a nonsignificant trend toward reduced risk for the primary end point (nonfatal and fatal MI) favoring amlodipine/perindopril treatment [ 24 ].